Eloïse Hudry

5.9k total citations · 3 hit papers
49 papers, 4.1k citations indexed

About

Eloïse Hudry is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eloïse Hudry has authored 49 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Physiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eloïse Hudry's work include Alzheimer's disease research and treatments (25 papers), Virus-based gene therapy research (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Eloïse Hudry is often cited by papers focused on Alzheimer's disease research and treatments (25 papers), Virus-based gene therapy research (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Eloïse Hudry collaborates with scholars based in United States, Spain and France. Eloïse Hudry's co-authors include Bradley T. Hyman, Luk H. Vandenberghe, Brian J. Bacskai, Michal Arbel‐Ornath, Zhanyun Fan, Tadafumi Hashimoto, Casey A. Maguire, Steven S. Hou, Rebecca A. Betensky and Sudeshna Das and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eloïse Hudry

49 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques

2019 539 citations Carlo Sala Frigerio, Leen Wolfs et al. Cell Reports profile →
Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

2020 315 citations María Calvo-Rodríguez, Steven S. Hou et al. Nature Communications profile →
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality

2019 280 citations Eloïse Hudry, Luk H. Vandenberghe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eloïse Hudry United States	28	1.8k	1.8k	1.1k	1.1k	576	49	4.1k
Diego Mastroeni United States	30	2.8k 1.5×	1.9k 1.1×	980 0.9×	568 0.5×	642 1.1×	60	4.6k
Tiziana Borsello Italy	31	2.1k 1.2×	1.5k 0.9×	742 0.7×	1.2k 1.1×	244 0.4×	82	4.1k
J. Colleen Karlo United States	15	1.6k 0.9×	1.7k 0.9×	1.6k 1.5×	589 0.6×	285 0.5×	15	4.0k
Hyang‐Sook Hoe South Korea	32	1.5k 0.8×	1.4k 0.8×	620 0.6×	832 0.8×	240 0.4×	92	3.3k
Wayne W. Poon United States	34	2.2k 1.2×	2.5k 1.4×	1.1k 1.0×	1.3k 1.2×	177 0.3×	52	4.7k
Ina Tesseur Belgium	25	1.6k 0.8×	2.3k 1.3×	762 0.7×	974 0.9×	166 0.3×	41	3.7k
Jean‐Noël Octave Belgium	37	2.3k 1.3×	2.3k 1.3×	584 0.5×	1.1k 1.0×	207 0.4×	107	4.3k
Marc Gleichmann United States	27	2.0k 1.1×	1.2k 0.7×	580 0.5×	909 0.9×	203 0.4×	40	3.9k
Yungui Zhou United States	22	1.5k 0.8×	2.2k 1.2×	1.3k 1.2×	706 0.7×	166 0.3×	29	4.3k
John J. LaFrancois United States	24	1.4k 0.8×	2.6k 1.4×	608 0.6×	1.4k 1.3×	282 0.5×	36	4.5k

Countries citing papers authored by Eloïse Hudry

Since Specialization

Citations

This map shows the geographic impact of Eloïse Hudry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloïse Hudry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloïse Hudry more than expected).

Fields of papers citing papers by Eloïse Hudry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eloïse Hudry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloïse Hudry. The network helps show where Eloïse Hudry may publish in the future.

Co-authorship network of co-authors of Eloïse Hudry

This figure shows the co-authorship network connecting the top 25 collaborators of Eloïse Hudry. A scholar is included among the top collaborators of Eloïse Hudry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eloïse Hudry. Eloïse Hudry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vono, Maria, Tony del Rio, Philip Jarvis, et al.. (2025). Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeys. Molecular Therapy — Methods & Clinical Development. 33(4). 101602–101602. 1 indexed citations

Ramirez, Servio H., Jonathan F. Hale, Siobhán McCarthy, et al.. (2023). An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature. Human Gene Therapy. 34(15-16). 682–696. 11 indexed citations

Carrell, Ellie M., Yong Hong Chen, Paul T. Ranum, et al.. (2023). VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF. Molecular Therapy — Nucleic Acids. 33. 296–304. 5 indexed citations

Hudry, Eloïse, et al.. (2023). Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery. Molecular Therapy. 31(10). 2999–3014. 21 indexed citations

Meseck, Emily K., et al.. (2022). Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques. Toxicologic Pathology. 50(4). 415–431. 24 indexed citations

Amaral, Ana C., Beatriz Gomez Perez‐Nievas, Alicia González‐Martínez, et al.. (2021). Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience. 24(2). 102058–102058. 24 indexed citations

Serrano‐Pozo, Alberto, Zhaozhi Li, Ayush Noori, et al.. (2021). Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer’s disease. Nature Aging. 1(10). 919–931. 27 indexed citations

Calvo-Rodríguez, María, Steven S. Hou, Austin Snyder, et al.. (2020). Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease. Nature Communications. 11(1). 2146–2146. 315 indexed citations breakdown →

Perea, Gertrudis, Antonia Gutiérrez, Javier Vitórica, et al.. (2020). Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Molecular Neurodegeneration. 15(1). 35–35. 43 indexed citations

10.

Frigerio, Carlo Sala, Leen Wolfs, Nicola Fattorelli, et al.. (2019). The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques. Cell Reports. 27(4). 1293–1306.e6. 539 indexed citations breakdown →

11.

Prabhakar, Shilpa, Pike-See Cheah, Max Zinter, et al.. (2019). Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Molecular Therapy — Methods & Clinical Development. 15. 18–26. 19 indexed citations

12.

Hanlon, Killian S., Tetyana P. Buzhdygan, Ming J. Cheng, et al.. (2019). Selection of an Efficient AAV Vector for Robust CNS Transgene Expression. Molecular Therapy — Methods & Clinical Development. 15. 320–332. 103 indexed citations

13.

Kelly, Patricia, Eloïse Hudry, Steven S. Hou, & Brian J. Bacskai. (2018). In Vivo Two Photon Imaging of Astrocytic Structure and Function in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 10. 219–219. 17 indexed citations

14.

Hudry, Eloïse, Eva Andrés‐Mateos, Paul Lerner, et al.. (2018). Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65. Molecular Therapy — Methods & Clinical Development. 10. 197–209. 65 indexed citations

15.

Kara, Eleanna, Zhanyun Fan, Jacob A. Klickstein, et al.. (2017). Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay. Journal of Biological Chemistry. 292(36). 14720–14729. 17 indexed citations

16.

Hudry, Eloïse, Sunil Gandhi, Bence György, et al.. (2016). Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Therapy. 23(4). 380–392. 118 indexed citations

17.

Farrar, Christian T., Christopher William, Eloïse Hudry, Tadafumi Hashimoto, & Bradley T. Hyman. (2014). RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques. PLoS ONE. 9(2). e89901–e89901. 32 indexed citations

18.

Arbel‐Ornath, Michal, Eloïse Hudry, Katharina Eikermann‐Haerter, et al.. (2013). Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models. Acta Neuropathologica. 126(3). 353–364. 212 indexed citations

19.

Wu, Hai-Yan, Eloïse Hudry, Tadafumi Hashimoto, et al.. (2010). Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation. Journal of Neuroscience. 30(7). 2636–2649. 309 indexed citations

20.

Hudry, Eloïse, Debby Van Dam, Wim Kulik, et al.. (2009). Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease. Molecular Therapy. 18(1). 44–53. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact